Livanova Plc OR Sh (LIVN)

Dec 18, 2024, 8:30 AM EST - 4 weeks ago

RECOVER Clinical Study Shows Meaningful Benefits of LivaNova's VNS Therapy System in Select Secondary Endpoints for Unipolar Patients with Treatment-Resistant Depression

Dec 5, 2024, 9:00 AM EST - 6 weeks ago

LivaNova to Present Scientific Data at American Epilepsy Society 2024 Annual Meeting

Nov 14, 2024, 9:00 AM EST - 2 months ago

LivaNova to Present at the Stifel, Wolfe, and Piper Sandler Healthcare Conferences

Nov 11, 2024, 4:05 PM EST - 2 months ago

LivaNova Announces OSPREY Clinical Study Meets Primary Safety and Efficacy Endpoints

Oct 30, 2024, 2:30 PM EDT - 2 months ago

LivaNova PLC (LIVN) Q3 2024 Earnings Call Transcript

Oct 30, 2024, 6:00 AM EDT - 2 months ago

LivaNova Reports Third-Quarter 2024 Results

Oct 18, 2024, 3:45 AM EDT - 3 months ago

LivaNova: Economics Should Start Making Sustained Improvements

Oct 8, 2024, 9:00 AM EDT - 3 months ago

LivaNova Appoints Susan Podlogar as a New Director

Oct 4, 2024, 11:59 AM EDT - 3 months ago

LivaNova's New Strategy Could Unlock Revenue, Profit Gains, Analyst Predicts

Sep 25, 2024, 9:00 AM EDT - 4 months ago

LivaNova to Announce Third-Quarter 2024 Results

Aug 19, 2024, 9:00 AM EDT - 5 months ago

LivaNova to Present at the Baird Global Healthcare Conference

Jul 31, 2024, 1:57 PM EDT - 6 months ago

LivaNova PLC (LIVN) Q2 2024 Earnings Call Transcript

Jul 31, 2024, 6:00 AM EDT - 6 months ago

LivaNova Reports Second-Quarter 2024 Results

Jun 24, 2024, 6:24 PM EDT - 7 months ago

Federman & Sherwood Investigates LivaNova USA, Inc. for Data Breach

Jun 18, 2024, 9:00 AM EDT - 7 months ago

LivaNova to Announce Second-Quarter 2024 Results

Jun 6, 2024, 9:00 AM EDT - 8 months ago

LivaNova Provides Update on RECOVER Clinical Study Evaluating VNS Therapy for Treatment-Resistant Depression in Unipolar Patients

May 23, 2024, 9:00 AM EDT - 8 months ago

LivaNova to Present at the Goldman Sachs Healthcare Conference

May 1, 2024, 10:56 AM EDT - 9 months ago

LivaNova PLC (LIVN) Q1 2024 Earnings Call Transcript

May 1, 2024, 6:00 AM EDT - 9 months ago

LivaNova Reports First-Quarter 2024 Results

Apr 30, 2024, 9:00 AM EDT - 9 months ago

LivaNova Announces Ahmet Tezel, Ph.D., as Chief Innovation Officer

Apr 25, 2024, 4:03 PM EDT - 9 months ago

LivaNova Issues Notice to U.S. Patients Regarding Cybersecurity Incident

Mar 21, 2024, 9:00 AM EDT - 10 months ago

LivaNova to Announce First-Quarter 2024 Results

Mar 20, 2024, 9:00 AM EDT - 10 months ago

LivaNova Announces a Positive Predictive Outcome of Trial Success in its OSPREY Clinical Study for Moderate to Severe Obstructive Sleep Apnea

Mar 5, 2024, 9:55 PM EST - 11 months ago

LivaNova Announces Pricing of Private Offering of $300 Million of 2.50% Convertible Senior Notes Due 2029

Mar 4, 2024, 4:44 PM EST - 11 months ago

LivaNova Announces Proposed Private Offering of $300 Million of Convertible Senior Notes

Mar 4, 2024, 9:00 AM EST - 11 months ago

LivaNova to Present at the Barclays Global Healthcare Conference

BCS

Feb 21, 2024, 10:36 AM EST - 11 months ago

LivaNova PLC (LIVN) Q4 2023 Earnings Call Transcript

Feb 21, 2024, 6:00 AM EST - 11 months ago

LivaNova Reports Fourth-Quarter and Full-Year 2023 Results

Feb 5, 2024, 8:00 AM EST - 1 year ago

LivaNova Announces Vladimir A. Makatsaria as CEO and Board Director

Jan 8, 2024, 8:30 AM EST - 1 year ago

LivaNova to Wind Down Advanced Circulatory Support Business Unit

Jan 4, 2024, 9:00 AM EST - 1 year ago

LivaNova to Announce Fourth-Quarter and Full-Year 2023 Results

Dec 26, 2023, 6:00 PM EST - 1 year ago

LivaNova: Reaching End Of RECOVER And ANTHEM

Nov 9, 2023, 9:00 AM EST - 1 year ago

LivaNova to Present at the Piper Sandler Healthcare Conference

Nov 1, 2023, 1:26 PM EDT - 1 year ago

LivaNova PLC (LIVN) Q3 2023 Earnings Call Transcript

Nov 1, 2023, 6:00 AM EDT - 1 year ago

LivaNova Reports Third-Quarter 2023 Results

Oct 25, 2023, 9:00 AM EDT - 1 year ago

LivaNova to Present at the Stifel and Wolfe Healthcare Conferences

Oct 6, 2023, 8:30 AM EDT - 1 year ago

LivaNova Board Appoints J. Christopher Barry as New Director

Sep 21, 2023, 7:00 AM EDT - 1 year ago

LivaNova Announces Marco Dolci, President of Cardiopulmonary, to Retire at the End of 2023

Sep 20, 2023, 9:00 AM EDT - 1 year ago

LivaNova to Announce Third-Quarter 2023 Results

Aug 30, 2023, 4:05 PM EDT - 1 year ago

LivaNova Unveils Essenz In-Line Blood Monitor with U.S. FDA 510(k) Clearance and CE Mark

Jul 26, 2023, 1:10 PM EDT - 1 year ago

LivaNova PLC (LIVN) Q2 2023 Earnings Call Transcript

Jul 26, 2023, 6:00 AM EDT - 1 year ago

LivaNova Reports Second-Quarter 2023 Results

Jun 14, 2023, 9:00 AM EDT - 1 year ago

LivaNova to Announce Second-Quarter 2023 Results

Jun 13, 2023, 9:00 AM EDT - 1 year ago

LivaNova Announces 150th Bipolar Depression Patient Randomized in RECOVER Clinical Study

May 10, 2023, 12:35 PM EDT - 1 year ago

Primecap Management Pumps Up LivaNova Position

May 7, 2023, 11:48 AM EDT - 1 year ago

LivaNova PLC (LIVN) Q1 2023 Earnings Call Transcript

May 3, 2023, 6:00 AM EDT - 1 year ago

LivaNova Reports First-Quarter 2023 Results

Apr 14, 2023, 4:30 PM EDT - 1 year ago

LivaNova Board of Directors Announce Leadership Changes